Literature DB >> 26123235

Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country.

Zahra Alam-mehrjerdi1, Azarakhsh Mokri2, Kate Dolan3.   

Abstract

AIM: Methamphetamine use is a new health concern in Iran, the most populated Persian Gulf country. However, there is no well-documented literature. The current study objectives were to systematically review all published English and Persian studies of the prevalence of methamphetamine use, the general physical and psychiatric-related harms and the availability of methamphetamine treatment and harm reduction services for adult users in Iran.
MATERIALS AND METHODS: A comprehensive search of the international peer-reviewed and gray literature was undertaken. Multiple electronic and scientific English and Persian databases were systematically searched from January 2002 to September 2014. Additionally, English and Persian gray literature on methamphetamine use was sought using online gray literature databases, library databases and general online searches over the same period of time.
RESULTS: Nineteen thousand and two hundred and eight studies, reports and conference papers were identified but only 42 studies were relevant to the study objectives. They were mainly published in 2010-2014. The search results confirmed the seizures of methamphetamine (six studies), the prevalence of methamphetamine use among the general population (three studies), drug users (four studies), women (nine studies) and opiate users in opiate treatment programs (five studies). In addition, methamphetamine use had resulted in blood-borne viral infections (one study), psychosis and intoxication (ten studies). Different reasons had facilitated methamphetamine use. However, the Matrix Model, community therapy and harm reduction services (four studies) had been provided for methamphetamine users in some cities.
CONCLUSION: The current situation of methamphetamine use necessitates more research on the epidemiology and health-related implications. These studies should help in identifying priorities for designing and implementing prevention and educational programs. More active models of engagement with Persian methamphetamine users and the provision of services that meet their specific treatment needs are required.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Asia; HIV; Iran; Methamphetamine; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26123235     DOI: 10.1016/j.ajp.2015.05.036

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  15 in total

1.  An adaptive design to screen, treat, and retain people with opioid use disorders who use methamphetamine in methadone clinics (STAR-OM): study protocol of a clinical trial.

Authors:  Le Minh Giang; Nguyen Thu Trang; Nguyen Bich Diep; Dao Thi Dieu Thuy; Dinh Thanh Thuy; Han Dinh Hoe; Hoang Thi Hai Van; Thai Thanh Truc; Hoa H Nguyen; Nguyen Ly Lai; Pham Thi Dan Linh; Vu Thi Tuong Vi; Cathy J Reback; Arleen Leibowitz; Li Li; Chunqing Lin; Michael Li; Steve Shoptaw
Journal:  Trials       Date:  2022-04-23       Impact factor: 2.728

2.  Outcome of treatment in patients with methamphetamine poisoning in an Iranian tertiary care referral center.

Authors:  Parva Paydar; Ali Mohammad Sabzghabaee; Hooman Paydar; Nastaran Eizadi-Mood; Ali Joumaa
Journal:  J Res Pharm Pract       Date:  2015 Jul-Sep

3.  The pattern of substance use disorder in the United Arab Emirates in 2015: results of a National Rehabilitation Centre cohort study.

Authors:  Hiba Alblooshi; Gary K Hulse; Ahmed El Kashef; Hanan Al Hashmi; Mansour Shawky; Hamad Al Ghaferi; Habiba Al Safar; Guan K Tay
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-05-13

Review 4.  Women-only drug treatment services and needs in Iran: the first review of current literature.

Authors:  Zahra Alam-mehrjerdi; Reza Daneshmand; Mercedeh Samiei; Roya Samadi; Mohammad Abdollahi; Kate Dolan
Journal:  Daru       Date:  2016-02-18       Impact factor: 3.117

5.  Methamphetamine Use and Emergency Department Utilization: 20 Years Later.

Authors:  John R Richards; Sheiva Hamidi; Connor D Grant; Colin G Wang; Nabil Tabish; Samuel D Turnipseed; Robert W Derlet
Journal:  J Addict       Date:  2017-08-17

6.  Prevalence and Characteristics of Precore Mutation in Iran and Its Correlation with Genotypes of Hepatitis B.

Authors:  Ali Kargar Kheirabad; Gholamreza Farshidfar; Sadegh Nasrollaheian; Hamed Gouklani
Journal:  Electron Physician       Date:  2017-04-25

7.  Evaluation of blood lead level in methamphetamine users in Tehran.

Authors:  Babak Mostafazadeh; Shahin Shadnia; Mohammad Ali Tavakkoli; Hamid Reza Khoddami Vishteh
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-02-22

8.  Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths.

Authors:  Maryam Akhgari; Homeira Mobaraki; Afshar Etemadi-Aleagha
Journal:  Daru       Date:  2017-02-17       Impact factor: 3.117

9.  No evidence of subgroups found in amphetamine consumers in Iran.

Authors:  Atireza Bananej; Sabine Völkl-Kernstock; Otto Lesch; Henriette Walter; Katrin Skala
Journal:  Neuropsychiatr       Date:  2018-03-07

10.  The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country.

Authors:  Zahra Alam-Mehrjerdi; Mohammad Abdollahi
Journal:  Daru       Date:  2015-11-17       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.